Cargando…

Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma

Malignant mesothelioma (MM), is an intractable disease with limited therapeutic options and grim survival rates. Altered metabolic and mitochondrial functions are hallmarks of MM and most other cancers. Mitochondria exist as a dynamic network, playing a central role in cellular metabolism. MM cell l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lennon, Frances E., Cianci, Gianguido C., Kanteti, Rajani, Riehm, Jacob J., Arif, Qudsia, Poroyko, Valeriy A., Lupovitch, Eitan, Vigneswaran, Wickii, Husain, Aliya, Chen, Phetcharat, Liao, James K., Sattler, Martin, Kindler, Hedy L., Salgia, Ravi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832330/ https://www.ncbi.nlm.nih.gov/pubmed/27080907 http://dx.doi.org/10.1038/srep24578

Ejemplares similares

MET and PI3K/mTOR as a Potential Combinatorial Therapeutic Target in Malignant Pleural Mesothelioma
por: Kanteti, Rajani, et al.
Publicado: (2014)

EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesothelioma
por: Tan, Yi-Hung Carol, et al.
Publicado: (2019)

PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma
por: Kanteti, Rajani, et al.
Publicado: (2016)

Tumor volume is an independent predictor of survival in patients with malignant pleural mesothelioma
por: Kircheva, Diana Y, et al.
Publicado: (2015)

Sphingosine Kinase 1 Is Required for Mesothelioma Cell Proliferation: Role of Histone Acetylation
por: Kalari, Satish, et al.
Publicado: (2012)

Role of protein kinase C β and vascular endothelial growth factor receptor in malignant pleural mesothelioma: Therapeutic implications and the usefulness of Caenorhabditis elegans model organism
por: Loganathan, Sivakumar, et al.
Publicado: (2011)

Utilisation of a thoracic oncology database to capture radiological and pathological images for evaluation of response to chemotherapy in patients with malignant pleural mesothelioma
por: Carey, George B, et al.
Publicado: (2012)

Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma
por: Kanteti, Rajani, et al.
Publicado: (2018)

Comment on “EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach”
por: Vigneswaran, Wickii T., et al.
Publicado: (2020)

O-6-methylguanine-deoxyribonucleic acid methyltransferase methylation enhances response to temozolomide treatment in esophageal cancer
por: Hasina, Rifat, et al.
Publicado: (2013)

Malignant Pleural Mesothelioma: Current Understanding of the Immune Microenvironment and Treatments of a Rare Disease
por: Tedesco, John, et al.
Publicado: (2022)

Systemic Treatments for Mesothelioma: Standard and Novel
por: Kindler, Hedy Lee
Publicado: (2008)

FAK and paxillin, two potential targets in pancreatic cancer
por: Kanteti, Rajani, et al.
Publicado: (2016)

Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy
por: White, Michael G., et al.
Publicado: (2020)

Extracellular Vesicles from Caveolin-Enriched Microdomains Regulate Hyaluronan-Mediated Sustained Vascular Integrity
por: Mirzapoiazova, Tamara, et al.
Publicado: (2015)

Modeling small cell lung cancer (SCLC) biology through deterministic and stochastic mathematical models
por: Salgia, Ravi, et al.
Publicado: (2018)

Exosomal miRNAs species in the blood of small cell and non-small cell lung cancer patients
por: Poroyko, Valeriy, et al.
Publicado: (2018)

Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer
por: Kanteti, Rajani, et al.
Publicado: (2014)

The Mu Opioid Receptor Promotes Opioid and Growth Factor-Induced Proliferation, Migration and Epithelial Mesenchymal Transition (EMT) in Human Lung Cancer
por: Lennon, Frances E., et al.
Publicado: (2014)

Novel Therapeutic Targets and Immune Dysfunction in Malignant Pleural Mesothelioma
por: Lapidot, Moshe, et al.
Publicado: (2022)

Update on the pathologic diagnosis of malignant mesothelioma
por: Schulte, Jefree J., et al.
Publicado: (2020)

Successful primary repair of late diagnosed spontaneous esophageal rupture: A case report
por: Kircheva, Diana Y., et al.
Publicado: (2017)

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
por: Surati, Mosmi, et al.
Publicado: (2011)

Application of immunohistochemistry in diagnosis and management of malignant mesothelioma
por: Chapel, David B., et al.
Publicado: (2020)

Video-Assisted Thoracoscopic Management of Post-Pneumonectomy Empyema
por: Podbielski, Francis J., et al.
Publicado: (1997)

Surgical treatment of pulmonary hypertension: Lung transplantation
por: Long, Jason, et al.
Publicado: (2011)

Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database
por: Surati, Mosmi, et al.
Publicado: (2011)

C. elegans and mutants with chronic nicotine exposure as a novel model of cancer phenotype
por: Kanteti, Rajani, et al.
Publicado: (2015)

Small Cell Lung Cancer Therapeutic Responses Through Fractal Measurements: From Radiology to Mitochondrial Biology
por: Mambetsariev, Isa, et al.
Publicado: (2019)

Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma
por: Mitchell, Owen D., et al.
Publicado: (2023)

Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation
por: Vigneswaran, Janani, et al.
Publicado: (2016)

A phase 2 randomized, double-blind, placebo-controlled study of tremelimumab for second and third line treatment in patients with unresectable pleural or peritoneal mesothelioma
por: Krug, Lee, et al.
Publicado: (2013)

The impact of marginal lung function on outcomes in the era of minimally invasive thoracic surgery
por: Nakahama, Hiroko, et al.
Publicado: (2021)

Pulmonary Parenchymal Changes in COVID-19 Survivors
por: Diaz, Ashley, et al.
Publicado: (2022)

Fractal dimension of coastline of Australia
por: Husain, Akhlaq, et al.
Publicado: (2021)

Editorial: The human microbiome: A new frontier in personalized cancer therapy
por: Poroyko, Valeriy, et al.
Publicado: (2022)

Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM)
por: Hassan, Raffit, et al.
Publicado: (2015)

Surgical Strategy of Complex Empyema Thoracis
por: Podbielski, Francis J., et al.
Publicado: (2000)

Thoracic Blastomycosis and Empyema
por: Wiesman, Irvin M., et al.
Publicado: (1999)

Robotic chest wall resection for primary benign chest wall tumors and locally advanced lung cancer: an institutional case series and national report
por: Verm, Raymond A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_emp45dfruq7sbn8uqginn28l3o